A Message on the Occasion of Nowruz!

Author :

Naraghi's Charity

Date: :

March 17, 2024

A Message on the Occasion of Nowruz!

Nahaleh Naraghi congratulated Nowroz!

As the vibrant colors of spring paint the world anew, we at Actoverco Group extend our heartfelt Nowruz greetings to you and your loved ones.

Nowruz, the Persian New Year, marks the beginning of a season filled with hope, joy, and rejuvenation. It is a time when we celebrate the beauty of nature’s renewal and the promise of brighter days ahead.

 

 

A Message From Nahaleh Naraghi

On this auspicious occasion, we reflect on the values of growth, resilience, and prosperity. Just as nature evolves and blossoms, so too does our commitment to innovation and advancement in the field of pharmaceuticals. We are dedicated to pioneering breakthroughs that enhance health and well-being, ensuring a brighter and healthier future for all.

As we embark on this new journey, let us embrace the spirit of Nowruz with optimism and unity. May the coming year be filled with success, prosperity, and abundant blessings for you and your family.

As a proud member of the Actoverco community, Actoverco remains steadfast in our pursuit of innovation and the relentless pursuit of improving lives. Together, let us embrace the challenges and opportunities that await us, confident in our ability to overcome obstacles and achieve new heights of success.

With sincere wishes for joy, prosperity, and success in the days ahead,

[Nahaleh Naraghi]

[Owner of Actoverco and Co-Founder of Dr. Naraghi’s Charity Organization]

Related News

Iran Supplex 2025

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

August 2, 2025

Labor Day Tribute from Actover

May 1, 2025

Nahaleh Naraqi honors Pharmacy Day with a special message!

August 27, 2024

nahale naraqi

Nahale Naraghi honors National Doctors Day in Iran!

August 22, 2024

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”

August 10, 2024

Visual Report on the Introduction of Actonib and Its application in Dermatology

July 31, 2024